Offerings (SEC Form D)
Each filing as reported by the issuer, newest first. Open a row for the full plain-English detail. D = original notice, D/A = amendment.
Offerings at a glance — 3 offerings, 4 filings (one row per SEC file number)
| File no. | Original Form D | Latest filing | Amendments | Offered (latest) | Sold (latest) | Industry (latest) |
|---|
| 021-324996 | Nov 2, 2018 EDGAR ↗ | Nov 2, 2018 D EDGAR ↗ | 0 | $750,000 | $750,000 | Other Health Care |
| 021-222221 | Aug 4, 2014 EDGAR ↗ | Aug 4, 2014 D EDGAR ↗ | 0 | $500,000 | $100,000 | Other Health Care |
| 021-151889 | Dec 15, 2010 EDGAR ↗ | May 6, 2013 D/A EDGAR ↗ | 1 latest May 6, 2013 | $1,000,000 | $896,000 | Other Health Care |
Offerings are grouped by SEC file number; rows without a file number (not yet retrieved from EDGAR) are shown as their own offering until the link is fetched.
Nov 2, 2018 D Other Health Care — $750,000 sold of $750,000 · 10 investors EDGAR ↗
| Filing | Form D filed Nov 2, 2018SEC file no. 021-324996 · accession 0001507765-18-000001 |
|---|
| Raise progress | $750,000 sold of $750,000 offered (100%) · $0 remaining · first sale Aug 24, 2016 |
|---|
| Filing timing | Date of first sale: Aug 24, 2016 · Form D filed: Nov 2, 2018 (800 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
|---|
| Time since first sale | 3,713 days (10.2 years) |
|---|
| Annual amendments | Issuer reported the offering is not expected to last more than one year. No amendment for this offering in our index (filings 2008 → Oct 22, 2026; checked Oct 23, 2026, 5:45 PM ET). Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
|---|
| Investors | 10 total · issuer reported no non-accredited investors |
|---|
| Exemption claimed | Rule 506(b) — no general advertising; up to 35 non-accredited investors allowed |
|---|
| Minimum investment accepted | $0 as filed (no minimum reported) |
|---|
| Securities offered | Other: Simple Agreement for Future Equity |
|---|
| Entity details | Organized in OREGON · formed more than five years before filing · revenue range: Decline to Disclose (state and year as reported on the issuer's latest filing) As reported by the issuer on Form D (Items 1–2 and 5). |
|---|
| Industry | Other Health Care |
|---|
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
|---|
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 |
|---|
| Signed by | Erik Swanson, by power of attorney, CFO (Nov 2, 2018) |
|---|
| Market context | Minimum investment: $0 as filed (no minimum reported). Typical range for similar offerings: $10,000–$54,310.
Offering size: $750,000. Typical range: $829,831–$9,999,998.
Investors: 10. Typical range: 2–15."Similar" = Other Health Care, Rule 506(b). Based on 4,189 Form D filings 2021–2026 in the same industry and exemption (Other Health Care, Rule 506(b); original Form D notices, one per offering) (Form D data, SEC). Ranges are the middle half (25th–75th percentile) of the filings that reported each value: minimum investment 1,330, offering size 3,970, investors 3,669. Computed by PartnerFacts as of Oct 23, 2026, 5:45 PM ET. No ranking or score. Source: PartnerFacts data & coverage. |
|---|
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET |
|---|
Aug 4, 2014 D Other Health Care — $100,000 sold of $500,000 · 4 investors EDGAR ↗
| Filing | Form D filed Aug 4, 2014SEC file no. 021-222221 · accession 0001507765-14-000002 |
|---|
| Raise progress | $100,000 sold of $500,000 offered (20%) · $400,000 remaining · first sale Mar 13, 2014 |
|---|
| Filing timing | Date of first sale: Mar 13, 2014 · Form D filed: Aug 4, 2014 (144 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
|---|
| Time since first sale | 4,608 days (12.6 years) |
|---|
| Annual amendments | Issuer reported the offering is not expected to last more than one year. No amendment for this offering in our index (filings 2008 → Oct 22, 2026; checked Oct 23, 2026, 5:45 PM ET). Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
|---|
| Investors | 4 total · issuer reported no non-accredited investors |
|---|
| Exemption claimed | Rule 506(b) — no general advertising; up to 35 non-accredited investors allowed |
|---|
| Minimum investment accepted | $25,000 |
|---|
| Securities offered | Debt |
|---|
| Entity details | Organized in OREGON · formed more than five years before filing · revenue range: Decline to Disclose (state and year as reported on the issuer's latest filing) As reported by the issuer on Form D (Items 1–2 and 5). |
|---|
| Industry | Other Health Care |
|---|
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
|---|
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 |
|---|
| Signed by | David Roche, Chairman, Board of Directors (Aug 4, 2014) |
|---|
| Market context | Minimum investment: $25,000. Typical range for similar offerings: $10,000–$54,310.
Offering size: $500,000. Typical range: $829,831–$9,999,998.
Investors: 4. Typical range: 2–15."Similar" = Other Health Care, Rule 506(b). Based on 4,189 Form D filings 2021–2026 in the same industry and exemption (Other Health Care, Rule 506(b); original Form D notices, one per offering) (Form D data, SEC). Ranges are the middle half (25th–75th percentile) of the filings that reported each value: minimum investment 1,330, offering size 3,970, investors 3,669. Computed by PartnerFacts as of Oct 23, 2026, 5:45 PM ET. No ranking or score. Source: PartnerFacts data & coverage. |
|---|
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET |
|---|
May 6, 2013 D/A Other Health Care — $896,000 sold of $1,000,000 · 0 investors EDGAR ↗
| Filing | Form D/A (amendment) filed May 6, 2013 · amends 0001507765-10-000001 ↗SEC file no. 021-151889 · accession 0001507765-13-000001 · filing 2 of 2 in this offering |
|---|
| Raise progress | $896,000 sold of $1,000,000 offered (90%) · $104,000 remaining |
|---|
| Filing timing | Date of first sale: Yet to occur · Original Form D filed: Dec 15, 2010 · This amendment (Form D/A) filed: May 6, 2013 This row is an amendment. Rule: the original Form D is generally due within 15 days after the first sale; the rule sets no deadline measured from an amendment. Dates shown as reported; no conclusion is drawn. |
|---|
| Annual amendments | Issuer reported the offering is not expected to last more than one year. This filing is an amendment dated May 6, 2013. Most recent amendment for this offering in our index: this filing, May 6, 2013. Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
|---|
| Investors | 0 total · issuer reported no non-accredited investors |
|---|
| Exemption claimed | Rule 506 (filed before Sept 2013, when 506 was split into 506(b) and 506(c)) |
|---|
| Minimum investment accepted | $25,000 |
|---|
| Securities offered | Equity |
|---|
| Entity details | Organized in OREGON · formed more than five years before filing · revenue range: Decline to Disclose (state and year as reported on the issuer's latest filing) As reported by the issuer on Form D (Items 1–2 and 5). |
|---|
| Industry | Other Health Care |
|---|
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
|---|
| Money to insiders | Sales commissions: $0 (est.) · Finder's fees: $0 (est.) · Proceeds to officers, directors, promoters: $225,000 (est.) |
|---|
| Signed by | Sean Scorvo, CEO (May 6, 2013) |
|---|
| Changes vs previous filing | - total sold: $0 (Dec 15, 2010) → $896,000 (May 6, 2013)
- total offering: $500,000 (Dec 15, 2010) → $1,000,000 (May 6, 2013)
- remaining: $500,000 (Dec 15, 2010) → $104,000 (May 6, 2013)
Compared with the D filed Dec 15, 2010 ( EDGAR ↗). Fields compared: total sold, total offering, remaining, investors, non-accredited investors (count), non-accredited investors reported, minimum investment, sales commissions, finder's fees, proceeds to insiders, date of first sale, industry, fund type, exemption, revenue range, net asset value range, securities offered, may last more than one year, related persons, sales-compensation recipients. Amendment history as filed; no conclusion is drawn. |
|---|
| Market context | Not computed — the exemption as filed is Rule 506 before the Sept 2013 split into 506(b) and 506(c) (see Exemption claimed); ranges are computed only for offerings claiming Rule 506(b) or 506(c), compared with the last 5 years of filings. |
|---|
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET |
|---|
Dec 15, 2010 D Other Health Care — $0 sold of $500,000 · 0 investors EDGAR ↗
| Filing | Form D filed Dec 15, 2010SEC file no. 021-151889 · accession 0001507765-10-000001 · filing 1 of 2 in this offering |
|---|
| Raise progress | $0 sold of $500,000 offered (0%) · $500,000 remaining |
|---|
| Filing timing | Date of first sale: Yet to occur · Form D filed: Dec 15, 2010 Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
|---|
| Annual amendments | Issuer reported the offering is not expected to last more than one year. Most recent amendment for this offering in our index: May 6, 2013 (EDGAR ↗). Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
|---|
| Investors | 0 total · issuer reported no non-accredited investors |
|---|
| Exemption claimed | Rule 506 (filed before Sept 2013, when 506 was split into 506(b) and 506(c)) |
|---|
| Minimum investment accepted | $25,000 |
|---|
| Securities offered | Equity |
|---|
| Entity details | Organized in OREGON · formed more than five years before filing · revenue range: Decline to Disclose (state and year as reported on the issuer's latest filing) As reported by the issuer on Form D (Items 1–2 and 5). |
|---|
| Industry | Other Health Care |
|---|
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
|---|
| Money to insiders | Sales commissions: $0 (est.) · Finder's fees: $0 (est.) · Proceeds to officers, directors, promoters: $225,000 (est.) |
|---|
| Signed by | Sean Scorvo, CEO (Dec 13, 2010) |
|---|
| Market context | Not computed — the exemption as filed is Rule 506 before the Sept 2013 split into 506(b) and 506(c) (see Exemption claimed); ranges are computed only for offerings claiming Rule 506(b) or 506(c), compared with the last 5 years of filings. |
|---|
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET |
|---|
Amendment history — 1 amendment on this page, each compared with the filing before it in the same offering
| Amendment filed | File no. | Compared with | What changed (both values as filed) |
|---|
| May 6, 2013 EDGAR ↗ | 021-151889 | Dec 15, 2010 D | total sold: $0 (Dec 15, 2010) → $896,000 (May 6, 2013) · total offering: $500,000 (Dec 15, 2010) → $1,000,000 (May 6, 2013) · remaining: $500,000 (Dec 15, 2010) → $104,000 (May 6, 2013) |
Fields compared: total sold, total offering, remaining, investors, non-accredited investors (count), non-accredited investors reported, minimum investment, sales commissions, finder's fees, proceeds to insiders, date of first sale, industry, fund type, exemption, revenue range, net asset value range, securities offered, may last more than one year, related persons, sales-compensation recipients. Values as filed; no conclusion is drawn.
All Form D filings for this CIK on SEC EDGAR ↗. History: 0 new offerings in the last 12 months (new offering = a Form D that is not an amendment) · most recent filing Nov 2, 2018. Industry as reported, by offering: All 3 offerings reported: Other Health Care (2010–2018).
Key people 7
Officers, directors and promoters the issuer itself named on its Form D. Tap a name for every other deal they are on.
| Name | Relationship | Address state | On filings (first → last) | Also listed on |
|---|
| BW Bryan Wieden | Director | OR | Nov 2, 2018 on 1 of 4 filings listed on the latest filing | — |
| DR David Roche | Director, Executive Officer | OR | Aug 4, 2014 → Nov 2, 2018 on 2 of 4 filings listed on the latest filing | — |
| JE Jay Eisenlohr | Director | OR | Nov 2, 2018 on 1 of 4 filings listed on the latest filing | — |
| RD Ron Decker | Director | OR | Nov 2, 2018 on 1 of 4 filings listed on the latest filing | — |
| RF Roshan Fernando | Executive Officer, Director | OR | Aug 4, 2014 → Nov 2, 2018 on 2 of 4 filings listed on the latest filing | 2 other issuers |
| JG John Griffith | Executive Officer | OR | Dec 15, 2010 → May 6, 2013 on 2 of 4 filings not listed on the latest filing (Nov 2, 2018) | — |
| SS Sean Scorvo | Executive Officer, Director | OR | Dec 15, 2010 → May 6, 2013 on 2 of 4 filings not listed on the latest filing (Nov 2, 2018) | — |
Executive officers, directors and promoters as self-reported by the issuer, one row per person. Spellings of the same name (same first and last name, or the same full name that EDGAR split differently into middle and last name) with no conflicting middle initial are shown on one row (none on this issuer); dates and counts come from the filings that list each name. Licensed persons: FINRA BrokerCheck ↗ · SEC IAPD ↗.
Connections
Other issuers listing the same people:
Shared address: this business address appears on filings for 23 other issuers. Stated as a count only (suite numbers ignored) — many addresses are shared office buildings or registered agents. As of Oct 23, 2026, 5:45 PM ET.
Other offering types (Regulation A and Regulation Crowdfunding)
Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.
Adviser registration (Form ADV)
Searched SEC Form ADV bulk data (registered + exempt reporting advisers) (24,962 records as of Oct 2, 2026, 8:00 AM ET) — nothing matched MiddleGate, Inc..
Meta advertising
No Meta Pixel ids or Facebook / Instagram page links on file for MiddleGate, Inc. as of Oct 24, 2026 — the sponsor website is read for them once it is on file (runs automatically). Meta Ad Library: not searched by PartnerFacts (no API access); a one-tap Ad Library search is under Look further.
Public profiles
Public profiles official links and public statements, each with its source and date
No website or social profile named in MiddleGate, Inc.'s SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #246,330 of 374,652 in line (14 issuers searched so far).
Sources searched for a website: Form C data set (issuer websites as filed), Form ADV data set (Item 1.I of matched advisers) — as of Oct 23, 2026, 11:20 PM ET: none on file for this issuer. The sponsor website, the Internet Archive and GDELT news index are read only once a site is on file; a sponsor's website comes from the issuer's own filings (Form C issuer website; EDGAR company profile), an approved profile claim, Form ADV Item 1.I of its matched adviser, or a web search for the issuer name confirmed on the site's own homepage. We never collect personal or family accounts.
Entity standing: not checked (no official programmatic source for OR yet).
Export this report as PDF (all source links + data timestamp) · Premium
Request diligence pack (Premium) PartnerFacts asks the sponsor for the standard information pack and delivers it to you labelled "provided by the sponsor".
Corrections log
No corrections have been requested for this page.
Filing-to-filing changes are in Amendment history above.